Diagnosis and Therapeutic Management of Liver Fibrosis by MicroRNA

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2021 Aug 7

PMID 34360904

Citations 28

Authors

Tomoko Tadokoro

Asahiro Morishita

Tsutomu Masaki

Affiliations

Soon will be listed here.

Abstract

Remarkable progress has been made in the treatment and control of hepatitis B and C viral infections. However, fundamental treatments for diseases in which liver fibrosis is a key factor, such as cirrhosis, alcoholic/nonalcoholic steatohepatitis, autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis, are still under development and remain an unmet medical need. To solve this problem, it is essential to elucidate the pathogenesis of liver fibrosis in detail from a molecular and cellular perspective and to develop targeted therapeutic agents based on this information. Recently, microRNAs (miRNAs), functional RNAs of 22 nucleotides, have been shown to be involved in the pathogenesis of liver fibrosis. In addition, extracellular vesicles called "exosomes" have been attracting attention, and research is being conducted to establish noninvasive and extremely sensitive biomarkers using miRNAs in exosomes. In this review, we summarize miRNAs directly involved in liver fibrosis, miRNAs associated with diseases leading to liver fibrosis, and miRNAs related to complications of cirrhosis. We will also discuss the efficacy of each miRNA as a biomarker of liver fibrosis and pathology, and its potential application as a therapeutic agent.

Citing Articles

The Role of MicroRNAs in Liver Functioning: from Biogenesis to Therapeutic Approaches (Review).

Kozlov D, Rodimova S, Kuznetsova D Sovrem Tekhnologii Med. 2025; 15(5):54-79.

PMID: 39967915 PMC: 11832066. DOI: 10.17691/stm2023.15.5.06.

miR-372-3p represses hepatic stellate cell activation via the RhoC/ROCK pathway.

Ou S, Tang X, Li Z, Ouyang R, Lei Y, Chen G Cytotechnology. 2025; 77(2):60.

PMID: 39959789 PMC: 11828770. DOI: 10.1007/s10616-025-00715-9.

The interactive role of microRNA and other non-coding RNA in hepatitis B (HBV) associated fibrogenesis.

Sartorius K, Wang Y, Sartorius B, Antwi S, Li X, Chuturgoon A Funct Integr Genomics. 2025; 25(1):24.

PMID: 39847120 DOI: 10.1007/s10142-024-01519-4.

Novel insights into the role of immunomodulatory extracellular vesicles in the pathogenesis of liver fibrosis.

Li J, Yuan Y, Fu Q, Chen M, Liang H, Chen X Biomark Res. 2024; 12(1):119.

PMID: 39396032 PMC: 11470730. DOI: 10.1186/s40364-024-00669-8.

miRNA-221: A Potential Biomarker of Progressive Liver Injury in Chronic Liver Disease (CLD) due to Hepatitis B Virus (HBV) and Nonalcoholic Fatty Liver Disease (NAFLD).

Sutradhar P, Sultana N, Nessa A Int J Hepatol. 2024; 2024:4221368.

PMID: 39185365 PMC: 11343628. DOI: 10.1155/2024/4221368.

References

Morishita A, Masaki T . MicroRNAs as possible biomarkers for hepatocellular carcinoma. Hepatol Res. 2018; 48(7):499-501. DOI: 10.1111/hepr.13078. View

Vemuganti R, Silva V, Mehta S, Hazell A . Acute liver failure-induced hepatic encephalopathy s associated with changes in microRNA expression rofiles in cerebral cortex of the mouse [corrected]. Metab Brain Dis. 2014; 29(4):891-9. PMC: 8487459. DOI: 10.1007/s11011-014-9545-0. View

Chen L, Chen R, Velazquez V, Brigstock D . Fibrogenic Signaling Is Suppressed in Hepatic Stellate Cells through Targeting of Connective Tissue Growth Factor (CCN2) by Cellular or Exosomal MicroRNA-199a-5p. Am J Pathol. 2016; 186(11):2921-2933. PMC: 5222964. DOI: 10.1016/j.ajpath.2016.07.011. View

Thakral S, Ghoshal K . miR-122 is a unique molecule with great potential in diagnosis, prognosis of liver disease, and therapy both as miRNA mimic and antimir. Curr Gene Ther. 2014; 15(2):142-50. PMC: 4439190. DOI: 10.2174/1566523214666141224095610. View

Yoon J, Kim G, Lee Y, Park S, Tak W, Kweon Y . Clinical significance of microRNA-21 expression in disease progression of patients with hepatocellular carcinoma. Biomark Med. 2018; 12(10):1105-1114. DOI: 10.2217/bmm-2018-0096. View

Riaz F, Chen Q, Lu K, Osoro E, Wu L, Feng L . Inhibition of miR-188-5p alleviates hepatic fibrosis by significantly reducing the activation and proliferation of HSCs through PTEN/PI3K/AKT pathway. J Cell Mol Med. 2021; 25(8):4073-4087. PMC: 8051718. DOI: 10.1111/jcmm.16376. View

Oura K, Morishita A, Masaki T . Molecular and Functional Roles of MicroRNAs in the Progression of Hepatocellular Carcinoma-A Review. Int J Mol Sci. 2020; 21(21). PMC: 7664704. DOI: 10.3390/ijms21218362. View

Zhou W, Zhang Q, Qiao L . Pathogenesis of liver cirrhosis. World J Gastroenterol. 2014; 20(23):7312-24. PMC: 4064077. DOI: 10.3748/wjg.v20.i23.7312. View

Chen J, Yu Y, Li S, Liu Y, Zhou S, Cao S . MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy. J Cell Mol Med. 2017; 21(12):3679-3692. PMC: 5706581. DOI: 10.1111/jcmm.13278. View

10.

Kogure A, Kosaka N, Ochiya T . Cross-talk between cancer cells and their neighbors via miRNA in extracellular vesicles: an emerging player in cancer metastasis. J Biomed Sci. 2019; 26(1):7. PMC: 6330499. DOI: 10.1186/s12929-019-0500-6. View

11.

Jiang X, Kanda T, Wu S, Nakamura M, Miyamura T, Nakamoto S . Regulation of microRNA by hepatitis B virus infection and their possible association with control of innate immunity. World J Gastroenterol. 2014; 20(23):7197-206. PMC: 4064064. DOI: 10.3748/wjg.v20.i23.7197. View

12.

Lee E, Sung P, Kim J, Park D, Hur W, Yoon S . microRNA-99a Restricts Replication of Hepatitis C Virus by Targeting mTOR and de novo Lipogenesis. Viruses. 2020; 12(7). PMC: 7411587. DOI: 10.3390/v12070696. View

13.

Gao B, Bataller R . Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology. 2011; 141(5):1572-85. PMC: 3214974. DOI: 10.1053/j.gastro.2011.09.002. View

14.

Iacob D, Rosca A, Ruta S . Circulating microRNAs as non-invasive biomarkers for hepatitis B virus liver fibrosis. World J Gastroenterol. 2020; 26(11):1113-1127. PMC: 7093315. DOI: 10.3748/wjg.v26.i11.1113. View

15.

Chen L, Chen R, Kemper S, Charrier A, Brigstock D . Suppression of fibrogenic signaling in hepatic stellate cells by Twist1-dependent microRNA-214 expression: Role of exosomes in horizontal transfer of Twist1. Am J Physiol Gastrointest Liver Physiol. 2015; 309(6):G491-9. PMC: 4572411. DOI: 10.1152/ajpgi.00140.2015. View

16.

Thabut D, Shah V . Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension?. J Hepatol. 2010; 53(5):976-80. DOI: 10.1016/j.jhep.2010.07.004. View

17.

Cabral B, Hoffmann L, Bottaro T, Costa P, Ramos A, Coelho H . Circulating microRNAs associated with liver fibrosis in chronic hepatitis C patients. Biochem Biophys Rep. 2020; 24:100814. PMC: 7520427. DOI: 10.1016/j.bbrep.2020.100814. View

18.

Roderburg C, Urban G, Bettermann K, Vucur M, Zimmermann H, Schmidt S . Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology. 2010; 53(1):209-18. DOI: 10.1002/hep.23922. View

19.

Wang W, Liu R, Su Y, Li H, Xie W, Ning B . MicroRNA-21-5p mediates TGF-β-regulated fibrogenic activation of spinal fibroblasts and the formation of fibrotic scars after spinal cord injury. Int J Biol Sci. 2018; 14(2):178-188. PMC: 5821039. DOI: 10.7150/ijbs.24074. View

20.

Jimenez Calvente C, Tameda M, Johnson C, Del Pilar H, Lin Y, Adronikou N . Neutrophils contribute to spontaneous resolution of liver inflammation and fibrosis via microRNA-223. J Clin Invest. 2019; 129(10):4091-4109. PMC: 6763256. DOI: 10.1172/JCI122258. View